|
|
Our experience with intrathrombus rtPA in conjunction with intravenous heparin in patients with CVT is encouraging. This therapy should probably be regarded as unsafe in patients with obvious hemorrhage. Time to restore flow may be faster than with urokinase (an average 71 hours has been reported for 29 documented patients). Further evaluation of rtPA with heparin in CVT is warranted. |
|